Abstract
Purpose
According to current treatment guidelines, surgical resection of hepatocellular carcinoma (HCC) is mostly restricted to a limited subgroup of patients. Due to improved surgical techniques and perioperative management, liver resections may also be performed more extendedly and also in cirrhotic livers with clinical signs of portal hypertension in selected patients. In this study, the clinical and long-term outcomes of liver resection in HCC patients with or without liver cirrhosis were evaluated.
Methods
One hundred fifty-eight patients undergoing liver resection for primary HCC at our institution were identified. Logistic and Cox regression analyses were used to identify prognostic parameters for postoperative complications and survival.
Results
In our cohort of patients, there was no association between clinical parameters or extent of surgical resection and postoperative morbidity. Only Barcelona Clinic Liver Cancer (BCLC) stage C patients were at significantly higher risk for major complications (OR 5.27, P = 0.009). Risk factors influencing long-term survival were patient age (HR 1.026, P = 0.027) and BCLC stage C (HR 3.47, P = 0.002). Compared to patients without liver cirrhosis, BCLC stage A and B patients undergoing resection were at similar risk for the development of severe complications and long-term mortality.
Conclusion
Liver resection as potentially curative therapy can be performed in selected patients in BCLC stage B, as well as in patients with clinical signs of portal hypertension. The resection of HCC-classified BCLC stage C is feasible but associated with significant morbidity and mortality.
Similar content being viewed by others
References
Bruix J, Sherman M (2011) Management of hepatocellular carcinoma: an update. Hepatology 53(3):1020–1022. doi:10.1002/hep.24199
Bruix J, Sherman M (2005) Management of hepatocellular carcinoma. Hepatology 42(5):1208–1236. doi:10.1002/hep.20933
Verslype C, Rosmorduc O, Rougier P, Group EGW (2012) Hepatocellular carcinoma: ESMO-ESDO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 23(Suppl 7):vii41–vii48. doi:10.1093/annonc/mds225
Llovet JM, Burroughs A, Bruix J (2003) Hepatocellular carcinoma. Lancet 362(9399):1907–1917. doi:10.1016/s0140-6736(03)14964-1
Henderson JM, Sherman M, Tavill A, Abecassis M, Chejfec G, Gramlich T (2003) AHPBA/AJCC consensus conference on staging of hepatocellular carcinoma: consensus statement. HPB (Oxford) 5(4):243–250. doi:10.1080/13651820310015833
Schnitzbauer AA, Lang SA, Goessmann H, Nadalin S, Baumgart J, Farkas SA, Fichtner-Feigl S, Lorf T, Goralcyk A, Horbelt R, Kroemer A, Loss M, Rummele P, Scherer MN, Padberg W, Konigsrainer A, Lang H, Obed A, Schlitt HJ (2012) Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann Surg 255(3):405–414. doi:10.1097/SLA.0b013e31824856f5
Poon RT, Fan ST, Lo CM, Ng IO, Liu CL, Lam CM, Wong J (2001) Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years. Ann Surg 234(1):63–70
Earl TM, Chapman WC (2013) Hepatocellular carcinoma: resection versus transplantation. Semin Liver Dis 33(3):282–292. doi:10.1055/s-0033-1351783
Thomas MB, Zhu AX (2005) Hepatocellular carcinoma: the need for progress. J Clin Oncol 23(13):2892–2899. doi:10.1200/JCO.2005.03.196
El-Serag HB, Marrero JA, Rudolph L, Reddy KR (2008) Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology 134(6):1752–1763. doi:10.1053/j.gastro.2008.02.090
Jarnagin W, Chapman WC, Curley S, D’Angelica M, Rosen C, Dixon E, Nagorney D, American Hepato-Pancreato-Biliary A, Society of Surgical O, Society for Surgery of the Alimentary T (2010) Surgical treatment of hepatocellular carcinoma: expert consensus statement. HPB (Oxford) 12(5):302–310. doi:10.1111/j.1477-2574.2010.00182.x
Vauthey JN, Dixon E, Abdalla EK, Helton WS, Pawlik TM, Taouli B, Brouquet A, Adams RB, American Hepato-Pancreato-Biliary A, Society of Surgical O, Society for Surgery of the Alimentary T (2010) Pretreatment assessment of hepatocellular carcinoma: expert consensus statement. HPB (Oxford) 12(5):289–299. doi:10.1111/j.1477-2574.2010.00181.x
Yamakado K, Kudo M (2014) Treatment strategies of intermediate-stage hepatocellular carcinomas in Japan (Barcelona Clinic Liver Cancer stage B). Oncology 87(Suppl 1):78–81. doi:10.1159/000368149
European Association For The Study Of The L, European Organisation For R, Treatment Of C (2012) EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 56(4):908–943. doi:10.1016/j.jhep.2011.12.001
Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213
Wong TC, Lo CM (2013) Resection strategies for hepatocellular carcinoma. Semin Liver Dis 33(3):273–281. doi:10.1055/s-0033-1351782
Sangiovanni A, Manini MA, Iavarone M, Romeo R, Forzenigo LV, Fraquelli M, Massironi S, Della Corte C, Ronchi G, Rumi MG, Biondetti P, Colombo M (2010) The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis. Gut 59(5):638–644. doi:10.1136/gut.2009.187286
Willatt JM, Hussain HK, Adusumilli S, Marrero JA (2008) MR imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies. Radiology 247(2):311–330. doi:10.1148/radiol.2472061331
Vauthey JN, Lauwers GY, Esnaola NF, Do KA, Belghiti J, Mirza N, Curley SA, Ellis LM, Regimbeau JM, Rashid A, Cleary KR, Nagorney DM (2002) Simplified staging for hepatocellular carcinoma. J Clin Oncol 20(6):1527–1536
Torzilli G, Belghiti J, Kokudo N, Takayama T, Capussotti L, Nuzzo G, Vauthey JN, Choti MA, De Santibanes E, Donadon M, Morenghi E, Makuuchi M (2013) A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL/AASLD recommendations?: an observational study of the HCC East-West study group. Ann Surg 257(5):929–937. doi:10.1097/SLA.0b013e31828329b8
Poon RT, Fan ST, Lo CM, Liu CL, Lam CM, Yuen WK, Yeung C, Wong J (2002) Extended hepatic resection for hepatocellular carcinoma in patients with cirrhosis: is it justified? Ann Surg 236(5):602–611. doi:10.1097/01.SLA.0000033038.38956.5E
Vitale A, Burra P, Frigo AC, Trevisani F, Farinati F, Spolverato G, Volk M, Giannini EG, Ciccarese F, Piscaglia F, Rapaccini GL, Di Marco M, Caturelli E, Zoli M, Borzio F, Cabibbo G, Felder M, Gasbarrini A, Sacco R, Foschi FG, Missale G, Morisco F, Svegliati Baroni G, Virdone R, Cillo U, Italian Liver Cancer Group (2015) Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: a multicentre study. J Hepatol 62(3):617–624. doi:10.1016/j.jhep.2014.10.037
Farinati F, Vanin V, Giacomin A, Pozzan C, Cillo U, Vitale A, Di Nolfo AM, Del Poggio P, Benvegnu L, Rapaccini G, Zoli M, Borzio F, Giannini EG, Caturelli E, Trevisani F, Italian Liver Cancer Group (2015) BCLC stage B hepatocellular carcinoma and transcatheter arterial chemoembolization: a 20-year survey by the Italian Liver Cancer group. Liver Int 35(1):223–231. doi:10.1111/liv.12649
Berzigotti A, Seijo S, Reverter E, Bosch J (2013) Assessing portal hypertension in liver diseases. Expert Rev Gastroenterol Hepatol 7(2):141–155. doi:10.1586/egh.12.83
Colombo M, Raoul JL, Lencioni R, Galle PR, Zucman-Rossi J, Banares R, Seehofer D, Neuhaus P, Johnson P (2013) Multidisciplinary strategies to improve treatment outcomes in hepatocellular carcinoma: a European perspective. Eur J Gastroenterol Hepatol 25(6):639–651. doi:10.1097/MEG.0b013e32835e33bb
Stockmann M, Lock JF, Malinowski M, Niehues SM, Seehofer D, Neuhaus P (2010) The LiMAx test: a new liver function test for predicting postoperative outcome in liver surgery. HPB (Oxford) 12(2):139–146. doi:10.1111/j.1477-2574.2009.00151.x
Seyama Y, Kokudo N (2009) Assessment of liver function for safe hepatic resection. Hepatol Res 39(2):107–116. doi:10.1111/j.1872-034X.2008.00441.x
Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft DK, AWMF) (2013) Diagnostik und Therapie des hepatozellulären Karzinoms, Langversion 1.0, AWMF Registrierungsnummer: 032-053OL.
Liu PH, Hsia CY, Lee YH, Hsu CY, Huang YH, Su CW, Lee RC, Lin HC, Huo TI (2015) Surgical resection versus transarterial chemoembolization for BCLC stage C hepatocellular carcinoma. J Surg Oncol 111(4):404–409. doi:10.1002/jso.23854
Author contributions
PR, JS, and SAF had full access to study data and took responsibility for the integrity and accuracy of data analysis. PR, ML, SAL, EKG, HJS, and SAF were responsible for the concept and design of the study. PR, JS, and SAF were responsible for the acquisition of data. PR, JS, AK, FZ, ML, SAL, EKG, HJS, and SAF performed the analysis and interpretation of data. PR, FZ, EKG, HJS, and SAF were responsible in the drafting of the manuscript. AK, ML, SAL, EKG, and HJS conducted the critical revision of the manuscript for important intellectual content. FZ, PR, and JS completed the statistical analysis. .EKG, HJS, SAF were responsible for the study supervision.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
All authors declare no conflict of interest related to this work. P. Renner receives funding from the German Research Society and Novartis. The retrospective analysis of our study cohort was in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Conflicts of interest
PR is financially supported by Novartis and the German Research Society (DFG) (not in relation with the manuscript).
Rights and permissions
About this article
Cite this article
Renner, P., Schuhbaum, J., Kroemer, A. et al. Morbidity of hepatic resection for intermediate and advanced hepatocellular carcinoma. Langenbecks Arch Surg 401, 43–53 (2016). https://doi.org/10.1007/s00423-015-1359-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00423-015-1359-y